Tag Archive | "GlaxoSmithKline"

GE and GlaxoSmithKline form biotech partnering for tumour genetic disorder

Tags: , , ,


GE Healthcare announced an biotech partnering agreement between its affiliate, Clarient Diagnostic Services and GlaxoSmithKline. Read the full story

Mylan bids on old drugs of GSK

Tags: , , , , ,


Several companies, including Mylan , have submitted a second round of bidding for a portfolio of older GlaxoSmithKline drugs.   Read the full story

Codexis signs a biotech licensing deal with GSK

Tags: ,


Codexis announced the signing of a biotech license agreement with GlaxoSmithKline. Read the full story

GSK makes a settlement of $105 million

Tags: ,


GSK agreed to pay $105 million to settle charges in California, New York, Texas and more than 40 other states that it illegally promoted its asthma drug Advair and antidepressants Wellbutrin and Paxil. Read the full story

GlaxoSmithKline looks to sell it older drugs

Tags: , , ,


GlaxoSmithKline  has invited private equity firms to consider making offers for a range of its older drugs sold in Western markets, according to three people with direct knowledge of the matter. Read the full story

Top 50 Pharma (top pharmaceutical companies)

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,


The term 'top pharma' can relate to the top pharmaceutical companies or the top 10 or 50... Read the full story

GlaxoSmithKline

Tags: ,


GlaxoSmithKline (GSK) is a top pharmaceutical company based in London, United Kingdom and Philadelphia, USA Read the full story

Pernix acquires GSK’s migraine product for $250 million

Tags: , , , , ,


Pernix Therapeutics has signed an agreement with GlaxoSmithKline to acquire the U.S rights to Treximet (sumatriptan / naproxen sodium) for the acute treatment of migraine attacks with or without aura in adults. Read the full story

Rumours swirl of Pfizer bid for AstraZeneca triggering M&A fever

Tags: , , , , , ,


The recently disclosed failed bid by Pfizer to acquire bigpharma rival AstraZeneca has analysts predicting several outcomes as M&A fever sweeps the pharma sector Read the full story

GSK and Anderson Cancer Center form a pharma alliance

Tags: , , ,


The University of Texas MD Anderson Cancer Center announced it formed a research pharma alliance with GlaxoSmithKline to strengthen its efforts in advancing therapies that train the body's immune system to combat cancer. Read the full story